| Detectable clonal mosaicism and its relationship to aging and cancer KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ... Nature genetics 44 (6), 651-658, 2012 | 663 | 2012 |
| Prognostic factors and outcomes for osteosarcoma: an international collaboration EE Pakos, AD Nearchou, RJ Grimer, HD Koumoullis, A Abudu, ... European journal of cancer 45 (13), 2367-2375, 2009 | 223 | 2009 |
| Genome-wide association study identifies two susceptibility loci for osteosarcoma SA Savage, L Mirabello, Z Wang, JM Gastier-Foster, R Gorlick, C Khanna, ... Nature genetics 45 (7), 799-803, 2013 | 201 | 2013 |
| Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types JN Sampson, WA Wheeler, M Yeager, O Panagiotou, Z Wang, SI Berndt, ... Journal of the National Cancer Institute 107 (12), djv279, 2015 | 181 | 2015 |
| Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients D Caronia, A Patino-Garcia, RL Milne, M Zalacain-Diez, G Pita, ... The pharmacogenomics journal 9 (5), 347-353, 2009 | 157 | 2009 |
| Germline TP53 Variants and Susceptibility to Osteosarcoma L Mirabello, M Yeager, PL Mai, JM Gastier-Foster, R Gorlick, C Khanna, ... Journal of the National Cancer Institute 107 (7), djv101, 2015 | 134 | 2015 |
| El ensayo de micronúcleos como medida de inestabilidad genética inducida por agentes genotóxicos M Zalacain, L Sierrasesumaga, A Patiño Anales del sistema sanitario de Navarra 28 (2), 227-236, 2005 | 112 | 2005 |
| Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis I González, EJ Andreu, A Panizo, S Inogés, A Fontalba, ... Clinical Cancer Research 10 (2), 751-761, 2004 | 110 | 2004 |
| Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on … Z Wang, B Zhu, M Zhang, H Parikh, J Jia, CC Chung, JN Sampson, ... Human molecular genetics 23 (24), 6616-6633, 2014 | 103 | 2014 |
| Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression A Patiño-García, M Zalacaín, L Marrodán, M San-Julián, ... The Journal of pediatrics 154 (5), 688-693, 2009 | 96 | 2009 |
| A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma L Mirabello, R Koster, BS Moriarity, LG Spector, PS Meltzer, J Gary, ... Cancer discovery 5 (9), 920-931, 2015 | 94 | 2015 |
| Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study D Caronia, A Patino-Garcia, A Peréz-Martínez, G Pita, LT Moreno, ... PLoS One 6 (10), e26091, 2011 | 92 | 2011 |
| Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples E Alava, MD Lozano, A Patiño-García, L Sierrasesúmaga, ... Lippincott, Williams & Wilkins, 1998 | 73 | 1998 |
| Transient posterior encephalopathy induced by chemotherapy in children R Sánchez-Carpintero, J Narbona, RL de Mesa, J Arbizu, ... Pediatric neurology 24 (2), 145-148, 2001 | 72 | 2001 |
| Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer E Ruza, E Sotillo, L Sierrasesúmaga, C Azcona, A Patiño-García Journal of pediatric hematology/oncology 25 (10), 780-786, 2003 | 61 | 2003 |
| Methotrexate pharmacokinetics and survival in osteosarcoma I Aquerreta, A Aldaz, J Giráldez, L Sierrasesúmaga Pediatric blood & cancer 42 (1), 52-58, 2004 | 60 | 2004 |
| CDH11 expression is associated with survival in patients with osteosarcoma G Nakajima, A Patiño-Garcia, S Bruheim, Y Xi, M San Julian, F Lecanda, ... Cancer genomics & proteomics 5 (1), 37-42, 2008 | 58 | 2008 |
| Limb salvage in bone sarcomas in patients younger than age 10: a 20-year experience M San-Julian, R Dölz, E Garcia-Barrecheguren, E Noain, ... Journal of Pediatric Orthopaedics 23 (6), 753-762, 2003 | 56 | 2003 |
| The cytogenetic assay as a measure of genetic instability induced by genotoxic agents M Zalacain, L Sierrasesumaga, A Patino Anales del sistema sanitario de Navarra 28 (2), 227-236, 2005 | 50 | 2005 |
| Pharmacodynamics of high-dose methotrexate in pediatric patients I Aquerreta, A Aldaz, J Giráldez, L Sierrasesúmaga Annals of Pharmacotherapy 36 (9), 1344-1350, 2002 | 49 | 2002 |
